Document is current
Any future updates will be listed below
-
Authors
Mitchell, Joshua D.
Panni, Usman
Fergestrom, Nicole
Toriola, Adetunji T.
Nywening, Timothy M.
Goedegebuure, S. Peter
Jiang, Xuntian
Mudd, Jacqueline L.
Cao, Yin
Ippolito, Joseph
Fields, Ryan C.
Hawkins, William G.
Peterson, Linda R.
- License Information
-
More Information
Article History
First Online: 25 October 2024
Disclosure
: Linda Peterson and Xuntian Jang are patent holders on the predictive value of the ceramide ratio for cardiovascular disease and congestive heart failure. Yin Cao previously served as a consultant for Geneoscopy for work unrelated to the subject matter. Joshua Mitchell has received research support from Abbott Laboratories, Myocardial Solutions, and Children’s Discovery Institute, unrelated to this manuscript, and has also received modest consulting fees from Alnylam, BridgeBio, Jazz Pharmaceuticals, Pfizer, Race Oncology, and Altathera for work unrelated to this manuscript. Usman Panni, Nicole Fergestrom, Adetunji T. Toriola, Timothy M. Nywening, S. Peter Goedegebuure, Jacqueline L. Mudd, Joseph Ippolito, Ryan C. Fields, and William G. Hawkins declare no potential conflicts of interest that may be relevant to the contents of this study.
